WHO ICTRP trial
A clinical study of hetrombopag combined with umbilical cord blood in the…
ChiCTR2300072983 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300072983 |
|---|---|
| Public title | A clinical study of hetrombopag combined with umbilical cord blood in the treatment of aplastic anemia |
| Scientific title | A clinical study of hetrombopag combined with umbilical cord blood in the treatment of aplastic anemia |
| Primary sponsor | Tianjin Medical University General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | aplastic anemia |
| Interventions | Experimental group:IST (ATG+CsA)+ hetrombopag + umbilical cord blood;Control group:IST (ATG+CsA)+ hetrombopag |
| Registration date | Jun 29, 2023 |
| Target size | Experimental group:25;Control group:25 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: